Analyst Price Targets — WW
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 8, 2026 1:29 pm | — | Morgan Stanley | $20.00 | $9.17 | TheFly | WW price target lowered to $20 from $21 at Morgan Stanley |
| January 15, 2026 12:20 pm | — | UBS | $34.50 | $26.02 | TheFly | WW price target lowered to $34.50 from $38 at Morgan Stanley |
| July 26, 2024 5:48 am | Nathan Feather | Morgan Stanley | $1.25 | $1.32 | TheFly | WW downgraded to Equal Weight from Overweight at Morgan Stanley |
| December 21, 2022 2:28 pm | Lind Bolton Weiser | D.A. Davidson | $6.00 | $3.74 | Benzinga | WW International In Right Hands To Kindle Growth, Says Analyst |
Latest News for WW
Polymarket and Kalshi traders have stayed completely silent on three struggling consumer brands facing serious balance sheet pressure, and that silence turns out to be one of the most revealing signals of all.
WW International, Inc. (WW) Q2 2026 Earnings Call Transcript
WW International (NASDAQ: WW), the parent company of Weight Watchers, reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million a year earlier, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook. The company said its second-quarter performance reflected progress in a multiyear transformation toward a business
WW International NASDAQ: WW, the parent company of Weight Watchers, reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million a year earlier, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook.
Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year Core+ End of Period Subscribers of 541 thousand, up 13.9% year-over-year, reflecting third consecutive quarter of sequential growth Revenue of $162.3 million; Clinical Subscription Revenue of $39.9 million, up 30.4% year-over-year Reaffirms Full Year 2026 Financial Guidance NEW YORK, Aug. 05,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.